Profs Weigh In On 3rd Circ. Lipitor Pay-For-Delay Row
A group of 48 professors has joined the American Antitrust Institute in urging the Third Circuit to revive allegations that Pfizer paid Ranbaxy to postpone a generic version of Lipitor, saying...To view the full article, register now.
Already a subscriber? Click here to view full article